Dr. Pugazhenthan Thangaraju
My Social Links

Dr. Pugazhenthan Thangaraju

Assistant Professor
All India Institute of Medical Sciences, Raipur, Chhattisgardh, India

Highest Degree
M.D. in Pharmacology from Postgraduate Institute of Medical Education and Research, India

Share this Profile

Biography

Pugazhenthan Thangaraju currently works at Department of Pharmacology, All India institute of medical sciences (AIIMS) Raipur. Previously worked in the Clinical division, Central Leprosy Teaching and Research Institute under Ministry of Health and Family Welfare, Government of India as Central Health services officer of Junior administrative grade. Pugazhenthan does research in Infectious Diseases

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacogenomics
62%
Pharmacovigilance
90%
Pharmacotherapy
75%
Lepra Reactions
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
97
Abstracts
1

Selected Publications

  1. Thangaraju, P., A.K. Balan, H. Velmurugan, S. Venkatesan and T.Y. SreeSudha, 2023. Leprosy reactions: Clinical pharmacologist perspective with repurposed medications. Infect. Disord. Drug Targets, Vol. 23. 10.2174/1871526522666220907125114.
    CrossRef  |  Direct Link  |  
  2. Zou, Z., G. Liu, S.I. Hay, S. Basu and U.I. Belgaumi, et al., 2022. Time trends in tuberculosis mortality across the BRICS: an age-period-cohort analysis for the GBD 2019. eClinical Med., 10.1016/j.eclinm.2022.101646.
    CrossRef  |  Direct Link  |  
  3. Yella, S.S.T., S.H.T. Yella, K.S.B.S.K. Sasanka and P. Thangaraju, 2022. Does methylene blue satisfy an option in COVID-19 ARDS. Infecti. Disord. - Drug Targets, 10.2174/1871526522666220317155947.
    CrossRef  |  Direct Link  |  
  4. Yella, S.S.T., P.K. Uppala, A.M. Varghese, H. Velmurugan, P. Thangaraju and K.S.B.S.K. Sasanka, 2022. Capecitabine and hand-foot syndrome: A case report. Infecti. Disord. - Drug Targets, 10.2174/1871526522666220614162117.
    CrossRef  |  Direct Link  |  
  5. Thangaraju, P., T.Y.S. Sudha and S. Venkatesan, 2022. Repurposing of drugs for non-responding erythema nodosum leprosum cases - A perspective. J. Young Pharm., 14: 266-267.
    CrossRef  |  Direct Link  |  
  6. Thangaraju, P., S.S.T. Yella, S.S.R. Lingareddygari and K.S.B.S.K. Sasanka, 2022. Repurposing thalidomide, its analogue and apremilast for possible antiviral in situation of severe COVID cytokine syndrome. Infect. Disord. Drug Targets, Vol. 22. 10.2174/1871526522666220811114816.
    CrossRef  |  Direct Link  |  
  7. Thangaraju, P., H. Velmurugan, S.S.T. Yella and S. Venkatesan, 2022. Vigilance needed in treating leprosy patients in accordance with WHO’s AWaRe. Recent Adv. Anti-Infective Drug Discovery, 17: 95-102.
    CrossRef  |  Direct Link  |  
  8. Thangaraju, P., H. Velmurugan, K. Neelambaran and S. Venkatesan, 2022. Time to be vigilant in contacts of leprosy for possible single-dose rifampicin. JAAD Case Reports, 29: 100-101.
    CrossRef  |  Direct Link  |  
  9. Thangaraju, P., G. Narasimhan, V.A. Ramamurthy, M.P. Gurunthalingam, S.S.T. Yella, S. Venkatesan and E. Thangaraju, 2022. Molecular docking analysis of Adhatoda vasica with thromboxane A2 receptor (TXA2R) (6IIU) and antiviral molecules for possible dengue complications. Infect. Disord. Drug Targets, 10.2174/1871526522666220718101544.
    CrossRef  |  Direct Link  |  
  10. Thangaraju, P. and H. Velmurugan, 2022. Diligence needed on treatment of primary multidrug-resistant pulmonary tuberculosis with concomitant COVID-19 infection. J. Family Med. Prim. Care, 11: 3391-3392.
    CrossRef  |  Direct Link  |  
  11. GBD 2019 Adolescent Transport and Unintentional Injuries Collaborators, 2022. Adolescent transport and unintentional injuries: A systematic analysis using the global burden of disease study 2019. Lancet Public Health, 7: e657-e669.
    CrossRef  |  Direct Link  |  
  12. Mehta, R., N.M. Nagarkar, A. Jindal, K.N. Rao and S.B. Nidhin, et al., 2021. Multidisciplinary management of COVID-associated mucormycosis syndemic in India. Indian J. Surg., 84: 934-942.
    CrossRef  |  Direct Link  |  
  13. Thangaraju, P., S. Venkatesan and V.K. Chadha, 2019. Needs monitoring with quetiapine. Chin. Med. J., 132: 113-114.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Venkatakrishnan, Y., P. Thangaraju, S. Jeganathan, S.K. Sankaran and R. Kannan, 2018. Nutritional status and morbidity profile of children with contact to leprosy in the rural community. bioRxiv. 10.1101/452995.
    CrossRef  |  Direct Link  |  
  15. Thangaraju, P., S. Venkatesan, T.T. Selvan, E. Sivshanmugam and M.S. Ali, 2018. The resurgence of leprosy in India: Findings from a survey assessing medical professionals' knowledge and preparedness. Educ. Health Profess., 1: 24-27.
    CrossRef  |  Direct Link  |  
  16. Thangaraju, P., S. Venkatesan, T. Tamilselvan, E. Sivashanmugam and M.S. Ali, 2018. Evaluation of awareness about pharmacovigilance and adverse drug reaction monitoring among medical professionals attending Central Leprosy Institute. Mustansiriya Med. J., 17: 63-68.
    CrossRef  |  Direct Link  |  
  17. Thangaraju, P., S. Venkatesan, E. Sivashanmugam and M.K.S. Ali, 2018. Target Hansen's disease. J. Family Med. Primary Care, 7: 838-838.
    CrossRef  |  PubMed  |  Direct Link  |  
  18. Thangaraju, P., S. Venkatesan and M.S. Ali, 2018. Final leprosy push: Out of society. Indian J. Community Med., 43: 58-59.
    CrossRef  |  PubMed  |  Direct Link  |  
  19. Thangaraju, P., 2018. First mobile application-Lepra reaction basic management guide-Stress on steroids. Indian J. Drugs Dermatol., 4: 85-86.
    CrossRef  |  Direct Link  |  
  20. Thangaraju, P. and S. Venkatesan, 2018. News from regulatory corner: Safety communication and recent drug approvals. Indian J. Drugs Dermatol., 4: 45-46.
    CrossRef  |  Direct Link  |  
  21. Thangaraju, P. and S. Venkatesan, 2018. Leprosy in children: Needs for active intervention. Chin. Med. J., 131: 1385-1385.
    CrossRef  |  PubMed  |  Direct Link  |  
  22. Pugazhenthan, T., S. Venkatesan, T. Tamilselvan, E. Sivashanmugam and M.K.S. Ali, 2018. Information on drugs used in management of lepra reactions in commonly used drug information sources in India. Indian J. Leprosy, 90: 129-136.
    Direct Link  |  
  23. Thangaraju, P., S. Venkatesan and M.K.S. Ali, 2017. Screening needed: Leprosy. Workplace Health Saf., 65: 332-332.
  24. Thangaraju, P., S. Venkatesan and A.M. Showkath, 2017. Leprosy case detection campaign (LCDC) for active surveillance. Trop. Doctor, 10.1177/0049475516686541.
    CrossRef  |  Direct Link  |  
  25. Thangaraju, P. and S. Venkatesan, 2017. Newer pharmacological Concepts of Managing Erythema Nodosum Leprosum: Hypothetical Approach. Lambert Academic Publishing, Germany, ISBN-13: 978-3659350672, Pages: 56.
  26. Pugazhenthan, T., Ravichandran, U. Aravindan, T. Tamilselvan, V.C. Giri and M.K.S. Ali, 2017. Evaluation of drug use pattern in central leprosy teaching and research institute as a tool to promote rational prescribing. Indian J. Leprosy, 89: 99-107.
    Direct Link  |  
  27. Pugazhenthan, T., H. Singh, A.T. Natrajan and M.S. Ali, 2017. Xanthogranulomatous pyelonephritis complicated by emphysematous pyelonephritis in lepra reaction patient-a very rare occurrence. Indian J. Leprosy, 89: 109-113.
    Direct Link  |  
  28. Goyal, A., H. Singh, V.K. Sehgal, C.R. Jayanthi and R. Munshi et al., 2017. Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study. Indian J. Med. Res., 146: 468-475.
    PubMed  |  Direct Link  |  
  29. Thangaraju, P., S. Venkatesan and M.K.S. Ali, 2017. Minocycline: A strategy for unresponsive nerve function impairment. Dermatol. Ther., .
    Direct Link  |  
  30. Thangaraju, P., V. Durai and M.K.S. Ali, 2016. The role of etanercept in refractory erythema nodosum leprosum. Int. J. Mycobacteriol., 5: 368-369.
    CrossRef  |  Direct Link  |  
  31. Michaelsamy, R., P. Thangaraju, V. Gunasekaran, R. Pushpharaj, V.C. Giri, A. Ulaganathan and A.M. Showkath, 2016. Effectiveness of the orientation training for laboratory technicians in leprosy skin smear and nasal smear techniquesin central leprosy teaching and research institute, India. Leprosy Rev., 87: 442-447.
    Direct Link  |  
  32. Thangaraju, P., T. Tamilselvan, S. Venkatesan, T. Eswaran, H. Singh, V.C. Giri and M.S. Ali, 2015. Topical phenytoin for managing various ulcers: A meta-analysis. Sudan Med. Monit., 10: 63-67.
    Direct Link  |  
  33. Thangaraju, P., S.K. Sengodan, V.C. Giri, U. Aravindan, R. Veerakumaran and M.K.S. Ali, 2015. Drug sensitivity and the changing patterns of bacterial isolates of infected ulcers of leprosy patients in central leprosy institute-retrospective analysis. Aust. J. Basic Applied Sci., 9: 469-473.
  34. Thangaraju, P., H. Singh, M.Punitha, V.C. Giri and M.K.S. Ali, 2015. Hyperpigmentation, a marker of rifampicin overuse in leprosy patient: An incidental finding. Sudan Med. Monit., 10: 25-26.
    CrossRef  |  Direct Link  |  
  35. Thangaraju, P., H. Singh, M. Punitha, V.C. Giri and S. Ali, 2015. Induction of hypothyroidism in Hashimoto's thyroiditis during leprosy treatment. Int. J. Adv. Med. Health Res., 2: 131-133.
  36. Thangaraju, P., H. Singh and A. Chakrabarti, 2015. Regorafenib: A novel tyrosine kinase inhibitor: A brief review of its therapeutic potential in the treatment of metastatic colorectal carcinoma and advanced gastrointestinal stromal tumors. Indian J. Cancer, 52: 257-260.
    CrossRef  |  Direct Link  |  
  37. Singh, H., P. Thangaraju and N.K. Natt, 2015. Sleep-walking a rarest side effect of zolpidem. Indian J. Psychol. Med., 37: 105-106.
    CrossRef  |  Direct Link  |  
  38. Thangaraju, P., V.C. Giri, H. Singh, V. Kumar and S. Ali, 2014. Tinea barbae: In released from treatment (RFT) Hansen’s disease patient. J. Clin. Diagn. Res., 8: YD01-YD02.
    CrossRef  |  Direct Link  |  
  39. Thangaraju, P., A. Chakrabarti, D. Banerjee and D. Hota, 2014. Dual blockade of renin angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model. N. Am. J. Med. Sci., 6: 625-632.
    CrossRef  |  Direct Link  |  
  40. Singh, H., P. Thangaraju, S. Kumar, U. Aravindan, H. Balasubramanian and T. Selvan, 2014. Knowledge and awareness of diabetes and diabetic ketoacidosis (DKA) among medical students in a tertiary teaching hospital: An observational study. J. Clin. Diagn. Res., 8: HC04-HC06.
    CrossRef  |  Direct Link  |  
  41. Pugazhenthan, T., H. Singh, P. Kumar and B. Hariharan, 2014. Is dysguesia going to be a rare or a common side-effect of amlodipine? Ann. Med. Health Sci. Res., 4: 43-44.
    Direct Link  |  
  42. Thangaraju, P., H. Singh, D. Banerjee and E. Thangaraju, 2013.. Beneficial effect of lard in androgenic alopecia. J. Rational Pharmacother. Res., 1: 144-146.
  43. Thangaraju, P., H. Singh, A. Chakrabarti and H. Balasubramanian, 2013. Antiplatelet theraphy and resistance. Int. J. Pharm. Sci. Res., 4: 4090-4097.
  44. Thangaraju, P., H. Singh and A. Chakrabarti, 2013. Treatment of deep and superficial infections of candida-what we know and what is new? Int. J. Pharm. Sci. Res., 4: 2562-2568.
  45. Singh, H., P. Thangaraju and B. Medhi, 2013. Acinetobacter baumannii, a threat to mankind-emergence of multidrug resistance. J. Clin. Diagn. Res., 7: 2602-2605.
  46. Singh, H., N.K. Natt, N. Garewal and T. Pugazhenthan, 2013. Bedaquiline: A new weapon against MDR and XDR-TB. Int. J. Basic Clin. Pharmacol., 2: 96-102.
    Direct Link  |  
  47. Singh, H., H. Kumar, P. Thangaraju and B. Medhi, 2013. Tafluprost: Adding new dimension to antiglaucoma therapy. Jk Sci., 15: 159-159.
  48. Singh, H., E. Arora, T. Pugazhenthan and B. Medhi, 2013. Enzalutamide as promising therapy in castrate resistant prostate cancer. JK Sci., 15: 105-107.
  49. Singh, H., E. Arora, P. Thangaraju, J. Singh and N.K. Natt, 2013. Antimicrobial resistance: New patterns, emerging concepts and prevention. J. Rational Pharmacother. Res., 1: 95-99.
  50. Deepak, B., T. Pugazhenthan, S. Saravanan and S. Kani, 2013. Carpopedal spasm-combined toxicity of hair dye poisoning-a case series. J. Rational Pharmacother. Res., 1: 140-143.
  51. Balasubramanian, D., H. Singh, P. Thangaraju and Saravanan, 2013. Cardiac arrest: Uncommon toxicity in hair dye poisoning-a case report. J. Rational Pharmacother. Res., 1: 72-74.